Virbac


Virbac is a French company dedicated to animal health. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 7th largest veterinarian pharmaceutical group with a turnover of 938 million euros in 2019. The company is a limited company with Executive and Supervisory Board. It has been listed on the Paris Stock Exchange since 1985 and is member of the SBF 120. The founder's family is the majority shareholder of the company.

History

Veterinarians Pierre-Richard Dick and Max Rombi founded Virbac in 1968 as a veterinary office in the Cap 3000 mall in Nice. The office was sold two years later, after which Dick and Rombi focussed on animal drugs for pets, distinguishing Virbac from large veterinary pharmaceutical companies that specialised in livestock.
At the end of the 1970s, Rombi began the subsidiary Arkovet, from where he developed Arkopharma, specialising in phyto- and nutrition therapy.

International growth

Virbac went international in 1983 with the establishment of offices in Egypt and Spain. Subsidiaries followed in the United States of America, Italy, Brazil, Australia, Germany, Mexico, Poland, Japan, and Belgium.
Virbac additionally acquired several companies:
Pierre-Richard Dick dies at sea at the age of 55. After his death in 1992, his family decided to keep the company.

Activities

The company has 4,900 employees and is present in over 100 countries with 33 sales subsidiaries. Its production is located in 10 countries among which France, the US, Mexico, Brazil, Vietnam. It also has seven research and development centers located in the United States, Mexico, Chile, Uruguay, France, Vietnam and Australia. It generates nearly 87% of its revenues outside France.
Its product range is designed to cover the main pathologies in companion animals and livestock: internal and external parasiticides, antibiotics, vaccines, diagnostic tests, dog and cat nutrition, dermatology, dental hygiene, reproductive, aquaculture, anesthesia, geriatrics and electronic identification.